According to a statement issued by the group, Bintai Healthcare has signed an agreement with Scientillence to jointly develop and market medical products in the
hemodialysis market, as well as to develop, invest, acquire or own dialysis centres, and other related renal care businesses in Malaysia and Southeast Asia.
Scientillence, owned by the ex-CEO and chairman of hospital group Pantai Holdings Bhd Tan Sri Lim Tong Yong, is the sole manufacturer of dialyser (artificial kidney) in Malaysia as well as Southeast Asia.
The partnership between Bintai Healthcare and Scientillence will facilitate Bintai Group to tap into the hemodialysis market as part of its business strategies to widen its range of products and services including distribution of medical devices and healthcare solutions in Malaysia.
“Pursuant to the agreement, both Bintai Healthcare and Scientillence will work together to explore and identify suitable new markets to expand and distribute Scientillence’s products and other products in the private and commercial sector such as non-governmental organisations,” said Bintai Kinden executive director Azri Azerai.
Scientillence will provide the necessary technical support and services in relation to the marketing and selling of the products, he added.